These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35148717)
1. Risk of sequelae after invasive meningococcal disease. Voss SS; Nielsen J; Valentiner-Branth P BMC Infect Dis; 2022 Feb; 22(1):148. PubMed ID: 35148717 [TBL] [Abstract][Full Text] [Related]
2. Sequelae at Hospital Discharge in 61 Children With Invasive Meningococcal Disease, Chile, 2009-2019. Arteta-Acosta C; Villena Martínez R; Santolaya de Pablo ME Pediatr Infect Dis J; 2022 Aug; 41(8):607-613. PubMed ID: 35421054 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis. Guedes S; Bricout H; Langevin E; Tong S; Bertrand-Gerentes I BMC Public Health; 2022 Mar; 22(1):521. PubMed ID: 35296287 [TBL] [Abstract][Full Text] [Related]
4. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954 [TBL] [Abstract][Full Text] [Related]
5. Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies. Thisyakorn U; Carlos J; Chotpitayasunondh T; Dien TM; Gonzales MLAM; Huong NTL; Ismail Z; Nordin MM; Ong-Lim ALT; Tantawichien T; Terumalay SD; Vu TD; Cintra O; Oladehin O Hum Vaccin Immunother; 2022 Nov; 18(6):2110759. PubMed ID: 36084311 [TBL] [Abstract][Full Text] [Related]
6. Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam. The Nguyen PN; Hung NT; Mathur G; Pinto TJP; Minh NHL Hum Vaccin Immunother; 2023 Dec; 19(1):2172922. PubMed ID: 36951161 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment. Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749 [TBL] [Abstract][Full Text] [Related]
8. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024 [TBL] [Abstract][Full Text] [Related]
10. The burden of invasive meningococcal disease in the Netherlands, 2011-2020. Middeldorp M; Steens A; Lagerweij G; van Sorge NM; Freudenburg-de Graaf W; A M Sanders E; de Melker HE; Knol MJ Vaccine; 2023 Apr; 41(16):2664-2670. PubMed ID: 36933982 [TBL] [Abstract][Full Text] [Related]
11. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations]. Křížová P; Vacková Z; Musílek M; Kozáková J Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175 [TBL] [Abstract][Full Text] [Related]
12. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis. Purmohamad A; Abasi E; Azimi T; Hosseini S; Safari H; Nasiri MJ; Imani Fooladi AA Microb Pathog; 2019 Sep; 134():103571. PubMed ID: 31163252 [TBL] [Abstract][Full Text] [Related]
13. Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain. Ivanova-Markova Y; González-Domínguez A; Hidalgo A; Sánchez R; García-Agua N; García-Ruiz AJ; Amanda Vallejo-Aparicio L; García A; Rodriguez R; de Gomensoro E; Gonzalez-Inchausti MDC; Shen J; Begum N; Tafalla M Vaccine; 2021 Dec; 39(52):7646-7654. PubMed ID: 34794819 [TBL] [Abstract][Full Text] [Related]
15. The Health Burden of Invasive Meningococcal Disease: A Systematic Review. Strifler L; Morris SK; Dang V; Tu HA; Minhas RS; Jamieson FB; Deeks SL; Crowcroft NS; Sander B J Pediatric Infect Dis Soc; 2016 Dec; 5(4):417-430. PubMed ID: 26501470 [TBL] [Abstract][Full Text] [Related]
16. Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region. Dogu AG; Oordt-Speets AM; van Kessel-de Bruijn F; Ceyhan M; Amiche A BMC Infect Dis; 2021 Oct; 21(1):1088. PubMed ID: 34686136 [TBL] [Abstract][Full Text] [Related]
17. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex. Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933 [TBL] [Abstract][Full Text] [Related]
18. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156 [TBL] [Abstract][Full Text] [Related]
19. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Meiring S; Cohen C; de Gouveia L; du Plessis M; Kularatne R; Hoosen A; Lekalakala R; Lengana S; Seetharam S; Naicker P; Quan V; Reubenson G; Tempia S; von Mollendorf C; von Gottberg A; Clin Infect Dis; 2019 Jul; 69(3):495-504. PubMed ID: 30351372 [TBL] [Abstract][Full Text] [Related]
20. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa. Taha MK; Presa J; Serra L Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]